Literature DB >> 7559454

Cloning and functional analysis of the promoter for KDR/flk-1, a receptor for vascular endothelial growth factor.

C Patterson1, M A Perrella, C M Hsieh, M Yoshizumi, M E Lee, E Haber.   

Abstract

KDR/flk-1 is one of two receptors for vascular endothelial growth factor, a potent angiogenic peptide. KDR/flk-1 is an early marker for endothelial cell progenitors, and its expression is restricted to endothelial cells in vivo. To investigate the molecular mechanisms regulating expression of KDR/flk-1, we cloned and characterized the promoter of the human KDR/flk-1 gene. The transcription start site was localized by primer extension and ribonuclease protection to a nucleotide 303 base pairs (bp) 5' of the initiation methionine codon. The 5'-flanking sequence is rich in G and C residues and contains five Sp1 elements but no TATA consensus sequence. By reporter gene transfection experiments, we found that approximately 4 kilobases of KDR/flk-1 5'-flanking sequence directed high level luciferase activity in bovine aortic endothelial cells; further deletion analysis revealed positive regulatory elements between bp -225 to -164, -95 to -77, -77 to -60, and +105 to +127. Mutation of an atypical GATA sequence between bp +105 and +127 did not affect promoter activity, suggesting that GATA elements are not essential for the high level promoter activity of this gene. Consistent with endothelial cell-restricted expression of KDR/flk-1 mRNA, we found that the 4-kilobase flanking sequence directed high level promoter activity in endothelial cells but not in other cell types. To our knowledge this is the first report characterizing the KDR/flk-1 promoter. Understanding the KDR/flk-1 promoter will allow us to investigate endothelial cell-specific gene regulation and to uncover methods for targeting gene delivery specifically to endothelial cells.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7559454     DOI: 10.1074/jbc.270.39.23111

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  48 in total

1.  Three-dimensional reconstruction of pulmonary arteries in plexiform pulmonary hypertension using cell-specific markers. Evidence for a dynamic and heterogeneous process of pulmonary endothelial cell growth.

Authors:  C D Cool; J S Stewart; P Werahera; G J Miller; R L Williams; N F Voelkel; R M Tuder
Journal:  Am J Pathol       Date:  1999-08       Impact factor: 4.307

Review 2.  Nonviral gene transfer strategies for the vasculature.

Authors:  Jennifer L Young; David A Dean
Journal:  Microcirculation       Date:  2002-01       Impact factor: 2.628

3.  Endogenous vascular endothelial growth factor-A (VEGF-A) maintains endothelial cell homeostasis by regulating VEGF receptor-2 transcription.

Authors:  Guangqi E; Ying Cao; Santanu Bhattacharya; Shamit Dutta; Enfeng Wang; Debabrata Mukhopadhyay
Journal:  J Biol Chem       Date:  2011-12-13       Impact factor: 5.157

4.  Activation of iCaspase-9 in neovessels inhibits oral tumor progression.

Authors:  M S Pinsky; W Song; Z Dong; K Warner; B Zeitlin; E Karl; D E Hall; J E Nör
Journal:  J Dent Res       Date:  2006-05       Impact factor: 6.116

5.  HoxB5 is an upstream transcriptional switch for differentiation of the vascular endothelium from precursor cells.

Authors:  Yaxu Wu; Martin Moser; Victoria L Bautch; Cam Patterson
Journal:  Mol Cell Biol       Date:  2003-08       Impact factor: 4.272

6.  A multi-gene transcriptional profiling approach to the discovery of cell signature markers.

Authors:  Youichiro Wada; Dan Li; Anne Merley; Andrew Zukauskas; William C Aird; Harold F Dvorak; Shou-Ching Shih
Journal:  Cytotechnology       Date:  2010-10-23       Impact factor: 2.058

7.  NANOG induction of fetal liver kinase-1 (FLK1) transcription regulates endothelial cell proliferation and angiogenesis.

Authors:  Erin E Kohler; Colleen E Cowan; Ishita Chatterjee; Asrar B Malik; Kishore K Wary
Journal:  Blood       Date:  2010-11-30       Impact factor: 22.113

Review 8.  Nuclear entry of nonviral vectors.

Authors:  D A Dean; D D Strong; W E Zimmer
Journal:  Gene Ther       Date:  2005-06       Impact factor: 5.250

9.  Dihydroartemisinin targets VEGFR2 via the NF-κB pathway in endothelial cells to inhibit angiogenesis.

Authors:  Fengyun Dong; Xia Zhou; Changsheng Li; Suhua Yan; Xianming Deng; Zhiqun Cao; Liqun Li; Bo Tang; Thaddeus D Allen; Ju Liu
Journal:  Cancer Biol Ther       Date:  2014       Impact factor: 4.742

10.  In vitro and in vivo analysis of expression cassettes designed for vascular gene transfer.

Authors:  S J White; E D Papadakis; C A Rogers; J L Johnson; E A L Biessen; A C Newby
Journal:  Gene Ther       Date:  2007-11-08       Impact factor: 5.250

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.